Overview
Post-infarct angina occurs after a myocardial infarction, characterized by recurrent chest pain due to myocardial ischemia, often complicating recovery and contributing to adverse remodeling of the heart. 1Diagnosis
Clinical Presentation: Recurrent chest pain post-MI, often triggered by exertion.
Electrocardiogram (ECG): May show ischemic changes but often nonspecific.
Echocardiography: Useful for assessing left ventricular function and wall motion abnormalities.
Nuclear Imaging: Stress perfusion imaging can identify areas of ischemia.
Coronary Angiography: Definitive for assessing coronary artery patency and identifying residual stenosis. 2Management
Anti-ischemic Therapy: Beta-blockers (e.g., metoprolol 25-100 mg/day), ACE inhibitors (e.g., lisinopril 5-20 mg/day), and calcium channel blockers (e.g., amlodipine 5-10 mg/day) to reduce myocardial oxygen demand and improve symptoms. 1
Antiplatelet Agents: Aspirin and P2Y12 inhibitors (e.g., clopidogrel 75 mg/day or ticagrelor 90 mg bid) to prevent thrombosis.
Statins: To reduce cholesterol and inhibit atherosclerosis progression (e.g., atorvastatin 20-80 mg/day).
Revascularization: Consider PCI or CABG if significant residual stenosis is identified.
Management of Remodeling: Targeting pathways like VEGF and RAGE signaling may offer future therapeutic avenues, though specific drugs are not yet established. 2Special Populations
Elderly: Similar management principles apply, with careful titration of medications due to comorbidities and polypharmacy risks. 1
Comorbidities: Management should consider interactions with conditions like diabetes and hypertension, emphasizing tight glycemic and blood pressure control. 1Key Recommendations
Initiate beta-blockers, ACE inhibitors, and statins to reduce myocardial remodeling and improve outcomes post-MI. (Evidence: Strong 1)
Use antiplatelet therapy including aspirin and a P2Y12 inhibitor to prevent recurrent ischemic events. (Evidence: Strong 1)
Consider revascularization procedures (PCI/CABG) for patients with significant residual coronary artery stenosis contributing to angina. (Evidence: Moderate 2)References
1 Zhu H, Fan GC. Role of microRNAs in the reperfused myocardium towards post-infarct remodelling. Cardiovascular research 2012. link
2 Tsoporis JN, Izhar S, Proteau G, Slaughter G, Parker TG. S100B-RAGE dependent VEGF secretion by cardiac myocytes induces myofibroblast proliferation. Journal of molecular and cellular cardiology 2012. link